Description

4H-1,4-Benzoxazine-4-Acetamide,2-Ethyl-2,3-Dihydro-n-(5-Methyl-2-Pyridinyl)-3-Oxo-(9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in research and development pipelines. It is primarily sought by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic institutions engaged in medicinal chemistry and drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of complex drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used as a scaffold or building block for constructing novel chemical libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• API Development: Integral in the process development and scale-up stages for new active pharmaceutical ingredients.
• Biochemical Research: May be utilized in the study of enzyme inhibition or receptor binding assays due to its specific molecular architecture.
• Fine Chemical Synthesis: Employed in multi-step organic syntheses requiring a high-purity, functionalized benzoxazine derivative.

Basic Information

Product Name	4H-1,4-Benzoxazine-4-Acetamide,2-Ethyl-2,3-Dihydro-n-(5-Methyl-2-Pyridinyl)-3-Oxo-(9Ci)
CAS No.	606119-37-3
Molecular Formula	C₁₈H₁₉N₃O₃
Molecular Weight	325.36 g/mol
Synonyms	2-Ethyl-2,3-dihydro-N-(5-methyl-2-pyridinyl)-3-oxo-4H-1,4-benzoxazine-4-acetamide; 4H-1,4-Benzoxazine-4-acetamide, 2-ethyl-2,3-dihydro-N-(5-methyl-2-pyridinyl)-3-oxo-; 606119-37-3; 2-Ethyl-N-(5-methylpyridin-2-yl)-3-oxo-2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carboxamide
EINECS	Contact for details

Quality Control

Our production of 4H-1,4-Benzoxazine-4-Acetamide,2-Ethyl-2,3-Dihydro-n-(5-Methyl-2-Pyridinyl)-3-Oxo-(9Ci) adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D. A Certificate of Analysis (COA) detailing all specifications is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.